SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Perez E.) "

Sökning: WFRF:(Perez E.)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Menditto, Enrica, et al. (författare)
  • Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study
  • 2019
  • Ingår i: Clinical and Experimental Allergy. - WILEY. - 0954-7894 .- 1365-2222. ; 49:4, s. 442-460
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12143 users were registered. A total of 6949 users reported at least one VAS data recording. Among them, 1887 users reported &gt;= 7 VAS data. About 1195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR &gt;= 70% and PDC &lt;= 1.25), 51 (4.23%) were partly adherent (MPR &gt;= 70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR &lt;70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.</p>
  •  
2.
  • Abdo, A. A., et al. (författare)
  • Multi-wavelength observations of the flaring gamma-ray blazar 3C 66A in 2008 October
  • 2011
  • Ingår i: Astrophysical Journal. - 0004-637X .- 1538-4357. ; 726:1, s. 43
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The BL Lacertae object 3C 66A was detected in a flaring state by the Fermi Large Area Telescope (LAT) and VERITAS in 2008 October. In addition to these gamma-ray observations, F-GAMMA, GASP-WEBT, PAIRITEL, MDM, ATOM, Swift, and Chandra provided radio to X-ray coverage. The available light curves show variability and, in particular, correlated flares are observed in the optical and Fermi-LAT gamma-ray band. The resulting spectral energy distribution can be well fitted using standard leptonic models with and without an external radiation field for inverse Compton scattering. It is found, however, that only the model with an external radiation field can accommodate the intra-night variability observed at optical wavelengths.</p>
  •  
3.
  • Aaltonen, T., et al. (författare)
  • Combination of measurements of the top-quark pair production cross section from the Tevatron Collider
  • 2014
  • Ingår i: Physical Review D. - 1550-7998 .- 1550-2368. ; 89:7
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>We combine six measurements of the inclusive top-quark pair (t(sic)) production cross section (sigma(t)(sic)) from data collected with the CDF and D0 detectors at the Fermilab Tevatron with proton-antiproton collisions at root s = 1.96 TeV. The data correspond to integrated luminosities of up to 8.8 fb(-1). We obtain a value of sigma tt = 7.60 +/- 0.41 pb for a top-quark mass of m(t) = 172.5 GeV. The contributions to the uncertainty are 0.20 pb from statistical sources, 0.29 pb from systematic sources, and 0.21 pb from the uncertainty on the integrated luminosity. The result is in good agreement with the standard model expectation of 7.35(-0.33)(+0.28) pb at next-to-next-to-leading order and next-to-next-to leading logarithms in perturbative QCD.</p>
  •  
4.
  • Aaltonen, T., et al. (författare)
  • Tevatron Constraints on Models of the Higgs Boson with Exotic Spin and Parity Using Decays to Bottom-Antibottom Quark Pairs
  • 2015
  • Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 114:15
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Combined constraints from the CDF and D0 Collaborations on models of the Higgs boson with exotic spin J and parity P are presented and compared with results obtained assuming the standard model value J(P) = 0(+). Both collaborations analyzed approximately 10 fb(-1) of proton-antiproton collisions with a center-of-mass energy of 1.96 TeV collected at the Fermilab Tevatron. Two models predicting exotic Higgs bosons with J(P) = 0(-) and J(P) = 2(+) are tested. The kinematic properties of exotic Higgs boson production in association with a vector boson differ from those predicted for the standard model Higgs boson. Upper limits at the 95% credibility level on the production rates of the exotic Higgs bosons, expressed as fractions of the standard model Higgs boson production rate, are set at 0.36 for both the J(P) = 0(-) hypothesis and the J(P) = 2(+) hypothesis. If the production rate times the branching ratio to a bottom-antibottom pair is the same as that predicted for the standard model Higgs boson, then the exotic bosons are excluded with significances of 5.0 standard deviations and 4.9 standard deviations for the J(P) = 0(-) and J(P) = 2(+) hypotheses, respectively.</p>
  •  
5.
  • Bousquet, Jean, et al. (författare)
  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology
  • 2019
  • Ingår i: Journal of Allergy and Clinical Immunology. - Elsevier. - 0091-6749 .- 1097-6825. ; 143:3, s. 864-879
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.</p>
  •  
6.
  • Dornelas, M., et al. (författare)
  • BioTIME: A database of biodiversity time series for the Anthropocene
  • 2018
  • Ingår i: Global Ecology and Biogeography. - 1466-822X. ; 27:7, s. 760-786
  • Tidskriftsartikel (refereegranskat)abstract
    • Motivation: The BioTIME database contains raw data on species identities and abundances in ecological assemblages through time. These data enable users to calculate temporal trends in biodiversity within and amongst assemblages using a broad range of metrics. BioTIME is being developed as a community-led open-source database of biodiversity time series. Our goal is to accelerate and facilitate quantitative analysis of temporal patterns of biodiversity in the Anthropocene. Main types of variables included: The database contains 8,777,413 species abundance records, from assemblages consistently sampled for a minimum of 2 years, which need not necessarily be consecutive. In addition, the database contains metadata relating to sampling methodology and contextual information about each record. Spatial location and grain: BioTIME is a global database of 547,161 unique sampling locations spanning the marine, freshwater and terrestrial realms. Grain size varies across datasets from 0.0000000158 km(2) (158 cm(2)) to 100 km(2) (1,000,000,000,000 cm(2)). Time period and grainBio: TIME records span from 1874 to 2016. The minimal temporal grain across all datasets in BioTIME is a year. Major taxa and level of measurement: BioTIME includes data from 44,440 species across the plant and animal kingdoms, ranging from plants, plankton and terrestrial invertebrates to small and large vertebrates.
  •  
7.
  • Pulit, S. L., et al. (författare)
  • Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
  • 2018
  • Ingår i: Neurology-Genetics. - 2376-7839. ; 4:6
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective We sought to assess whether genetic risk factors for atrial fibrillation (AF) can explain cardioembolic stroke risk. We evaluated genetic correlations between a previous genetic study of AF and AF in the presence of cardioembolic stroke using genome-wide genotypes from the Stroke Genetics Network (N = 3,190 AF cases, 3,000 cardioembolic stroke cases, and 28,026 referents). We tested whether a previously validated AF polygenic risk score (PRS) associated with cardioembolic and other stroke subtypes after accounting for AF clinical risk factors. We observed a strong correlation between previously reported genetic risk for AF, AF in the presence of stroke, and cardioembolic stroke (Pearson r = 0.77 and 0.76, respectively, across SNPs with p < 4.4 x 10(-4) in the previous AF meta-analysis). An AF PRS, adjusted for clinical AF risk factors, was associated with cardioembolic stroke (odds ratio [OR] per SD = 1.40, p = 1.45 x 10(-48)), explaining similar to 20% of the heritable component of cardioembolic stroke risk. The AF PRS was also associated with stroke of undetermined cause (OR per SD = 1.07,p = 0.004), but no other primary stroke subtypes (all p > 0.1). Genetic risk of AF is associated with cardioembolic stroke, independent of clinical risk factors. Studies are warranted to determine whether AF genetic risk can serve as a biomarker for strokes caused by AF.
  •  
8.
  • Aaltonen, T., et al. (författare)
  • Combination of CDF and D0 W-Boson mass measurements
  • 2013
  • Ingår i: Physical Review D. - 1550-7998 .- 1550-2368. ; 88:5, s. 052018
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>We summarize and combine direct measurements of the mass of the W boson in root s = 1.96 TeV proton-antiproton collision data collected by CDF and D0 experiments at the Fermilab Tevatron Collider. Earlier measurements from CDF and D0 are combined with the two latest, more precise measurements: a CDF measurement in the electron and muon channels using data corresponding to 2.2 fb(-1) of integrated luminosity, and a D0 measurement in the electron channel using data corresponding to 4.3 fb(-1) of integrated luminosity. The resulting Tevatron average for the mass of the W boson is M-W = 80387 +/- 16 MeV. Including measurements obtained in electron-positron collisions at LEP yields the most precise value of M-W = 80385 +/- 15 MeV.</p>
  •  
9.
  • Aaltonen, T., et al. (författare)
  • Higgs boson studies at the Tevatron
  • 2013
  • Ingår i: Physical Review D. - 1550-7998 .- 1550-2368. ; 88:5, s. 052014
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>We combine searches by the CDF and D0 Collaborations for the standard model Higgs boson with mass in the range 90-200 GeV/c(2) produced in the gluon-gluon fusion, WH, ZH, t (t) over barH, and vector boson fusion processes, and decaying in the H -&gt; b (b) over bar, H -&gt; W+W-, H -&gt; ZZ, H -&gt; tau(+)tau(-), and H -&gt; gamma gamma modes. The data correspond to integrated luminosities of up to 10 fb(-1) and were collected at the Fermilab Tevatron in p (p) over bar collisions at root s = 1.96 TeV. The searches are also interpreted in the context of fermiophobic and fourth generation models. We observe a significant excess of events in the mass range between 115 and 140 GeV/c(2). The local significance corresponds to 3.0 standard deviations at m(H) = 125 GeV/c(2), consistent with the mass of the Higgs boson observed at the LHC, and we expect a local significance of 1.9 standard deviations. We separately combine searches for H -&gt; b (b) over bar, H -&gt; W+W-, H -&gt; tau(+)tau(-), and H -&gt; gamma gamma. The observed signal strengths in all channels are consistent with the presence of a standard model Higgs boson with a mass of 125 GeV/c(2).</p>
  •  
10.
  • Aaltonen, T., et al. (författare)
  • Observation of s-Channel Production of Single Top Quarks at the Tevatron
  • 2014
  • Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 112:23
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>We report the first observation of single-top-quark production in the s channel through the combination of the CDF and D0 measurements of the cross section in proton-antiproton collisions at a center-of-mass energy of 1.96 TeV. The data correspond to total integrated luminosities of up to 9.7 fb(-1) per experiment. The measured cross section is sigma(s) = 1.29(-0.24)(+0.26) pb. The probability of observing a statistical fluctuation of the background to a cross section of the observed size or larger is 1.8 x 10(-10), corresponding to a significance of 6.3 standard deviations for the presence of an s-channel contribution to the production of single-top quarks.</p>
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (198)
Typ av publikation
tidskriftsartikel (1354)
konferensbidrag (61)
forskningsöversikt (13)
rapport (5)
annan publikation (4)
bokkapitel (4)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (1401)
övrigt vetenskapligt (82)
populärvet., debatt m.m. (2)
Författare/redaktör
Dominguez, A. (197)
Adams, M. (193)
Alkhazov, G. (192)
Brown, D. (192)
Bernardi, G. (189)
Chakrabarti, S. (189)
visa fler...
Das, A. (189)
Davies, G. (189)
Abbott, B., (188)
Brandt, A. (188)
Brock, R. (188)
Bernhard, R. (188)
Burdin, S. (188)
Abazov, V. M. (188)
Adams, T. (188)
Alton, A. (188)
Askew, A. (188)
Avila, C. (188)
Bagby, L. (188)
Baldin, B. (188)
Bandurin, D. V. (188)
Barberis, E. (188)
Bartlett, J. F. (188)
Bean, A. (188)
Begalli, M. (188)
Bellantoni, L. (188)
Beuselinck, R. (188)
Bhatnagar, V. (188)
Blessing, S. (188)
Boehnlein, A. (188)
Boos, E. E. (188)
Bross, A. (188)
Buehler, M. (188)
Bunichev, V. (188)
Camacho-Perez, E. (188)
Chandra, A. (188)
Choi, S. (188)
Choudhary, B. (188)
Cho, S. W. (188)
Cihangir, S. (188)
Claes, D. (188)
Corcoran, M. (188)
Cutts, D. (188)
Denisov, D. (188)
Desai, S. (188)
de Jong, S. J. (188)
De La Cruz-Burelo, E ... (188)
Diehl, H. T. (188)
Diesburg, M. (188)
Dubey, A. (188)
visa färre...
Lärosäte
Uppsala universitet (464)
Karolinska Institutet (324)
Lunds universitet (298)
Stockholms universitet (110)
Linnéuniversitetet (79)
Chalmers tekniska högskola (65)
visa fler...
Göteborgs universitet (64)
Umeå universitet (48)
Kungliga Tekniska Högskolan (39)
Linköpings universitet (19)
Mittuniversitetet (6)
RISE (3)
Örebro universitet (2)
Karlstads universitet (2)
Luleå tekniska universitet (1)
Högskolan i Jönköping (1)
Naturhistoriska riksmuseet (1)
visa färre...
Språk
Engelska (1430)
Svenska (2)
Spanska (2)
Odefinierat språk (1)
Polska (1)
Portugisiska (1)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (863)
Medicin och hälsovetenskap (258)
Teknik (31)
Lantbruksvetenskap (8)
Samhällsvetenskap (7)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy